Study limitation: The study population was predominantly stage III (90.9%) with ECOG 0, limiting generalizability to other disease stages or performance statuses | ReachRx
Prophylactic Medium-Class Topical Steroids are Associated with a Lower Incidence of Capecitabine-Induced Hand-Foot Syndrome in Patients with Colorectal Cancer
Study limitation reported by the research below: “The study population was predominantly stage III (90.9%) with ECOG 0, limiting generalizability to other disease stages or performance statuses.”
